期刊文献+

中耳胆脂瘤相关因子

下载PDF
导出
摘要 中耳胆脂瘤的病理过程极其复杂,是众多因素共同作用的结果,许多学者从分子生物学的角度对胆脂瘤上皮中细胞因子的表达和相互作用进行了研究,表明众多细胞因子在中耳胆脂瘤的形成中起作用。
作者 敖红敏 张剑
出处 《中国眼耳鼻喉科杂志》 2009年第2期128-129,共2页 Chinese Journal of Ophthalmology and Otorhinolaryngology
  • 相关文献

参考文献16

  • 1YARDEN Y, ULLRICH A. Growth factor receptor tyrosine kinases [J]. Annu Rev Biochem,1988,57(4) :443-478.
  • 2VITALE R F, RIBEIRO FDE A. The role of tumor necrosis factoralpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma [ J ]. Braz J Otorhinolaryngol,2007,73 ( 1 ) : 117-121.
  • 3徐洁,李朝军,夏琛,李增鹏,杨宇馨.肿瘤坏死因子受体1在中耳胆脂瘤上皮中的表达[J].中华耳科学杂志,2007,5(1):94-97. 被引量:3
  • 4MASSUDA E T, OLIVEIRA J A. A new experimental model of acquired cholesteatoma [ J ]. Laryngoscope, 2005, 115 ( 3 ) : 481-485.
  • 5刘建治,林国经,黄建民,江张舟.基质金属蛋白酶-1及白细胞介素-1αmRNA在中耳胆脂瘤上皮中的表达[J].中华耳鼻咽喉科杂志,2002,37(1):30-33. 被引量:6
  • 6AKIMOTO R, PAWANKAR R, YAGI T, et al. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-l, interleukin-l-alpha and lymphocyte functional antigen-1 in the inflammatory process[ J]. ORL J Otorhinolaryngol Relat Spec ,2000,62 ( 5 ) :257-265.
  • 7YOSHIKAWA M, KOJIMA H, WADA K, et al. Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma [ J ]. Arch Otolaryngol Head Neck Surg, 2006,132 (7) : 734-742.
  • 8黎万荣,陈正侬.转化生长因子Α和Β1在中耳胆脂瘤中的表达及其意义[J].中华耳鼻咽喉头颈外科杂志,2005,40(12):935-936. 被引量:3
  • 9HUISMAN M A, DE HEER E, TEN DIJKE P, et al. Transforming growth factor beta and wound healing in human cholesteatoma [ J ]. Laryngoscope ,2008,118 ( 1 ) :94-98.
  • 10孙文忠,徐志文,唐安洲,苏纪平.PTKs CDK4及p15在中耳胆脂瘤上皮的表达[J].临床耳鼻咽喉科杂志,2004,18(10):616-619. 被引量:7

二级参考文献49

  • 1[1]Bujia J,Kim C,Holly A,et al.Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma:an analysis of protein production and gene expression.Am J Otol,1996,17 (2):203-206.
  • 2[2]Bujia J,Kim C,Ostos-Aumente P,et al.Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.Eur Arch Otorhinolaryngol,1997,254 (1):6-8.
  • 3[3]Park HJ,Park K.Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma.Laryngoscope,1999,109 (4):613-616.
  • 4[4]Yan SD,Huang CC.Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro.Ann Otol Rhinol Larygol,1991,100 (2):157-161.
  • 5[5]Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414 (6865):813-820.
  • 6[6]Yetiser S,Satar B,Aydin N.Expression of epidermal growth factor,tumor necrosis factor-alpha,and interleukin-1alpha in chronic otitis media with or without cholesteatoma.Otol Neurotol,2002,23 (5):647-652.
  • 7[7]Chodynicki S,Soroczynska J.TNF alpha in serum of patients with cholesteatoma.Otolaryngol Pol,1994,48 (3):279-281.
  • 8[8]Akimoto R,Pawankar R,Yagi T,et al.Acquired and congenital cholesteatoma:determination of tumor necrosis factor alpha,intracellular adhesion molecule-1,interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.ORL J Otorhinolaryngol Relat Spec,2000,62 (5):257-265.
  • 9[9]Lavrik I,Golks A,Krammer PH.Death receptor signaling.J Cell Sci,2005,118 (Pt 2):265-267.
  • 10[10]Schneider-Brachert W,Tchikov V,Neumeyer J,et al.Compartmentalization of TNF receptor 1 signaling:internalized TNF receptosomes as death signaling vesicles.Immunity,2004,21 (3):415-428.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部